» Articles » PMID: 33554279

Intestinal and Hepatic Effects of Iron Oxide Nanoparticles

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2021 Feb 8
PMID 33554279
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Iron oxide nanoparticles gain increasing attention due to their broad industrial use. However, safety concerns exist since their effects on human cells are still under investigation. The presence of iron oxide nanoparticles in the food pigment E172 has been shown recently. Here, we studied four iron oxide nanoparticles, one food pigment E172 and the ionic control FeSO regarding dissolution in biological media, uptake and transport, and cellular effects in vitro in human intestinal Caco-2 and HepaRG hepatocarcinoma cells. The iron oxide nanoparticles passed the gastrointestinal passage without dissolution and reached the intestine in the form of particles. Minor uptake was seen into Caco-2 cells but almost no transport to the basolateral site was detected for any of the tested particles. HepaRG cells showed higher particle uptake. Caco-2 cells showed no alterations in reactive oxygen species production, apoptosis, or mitochondrial membrane potential, whereas two particles induced apoptosis in HepaRG cells, and one altered mitochondrial membrane potential at non-cytotoxic concentrations. No correlation between physicochemical particle characteristics and cellular effects was observed, thus emphasizing the need for case-by-case assessment of iron oxide nanoparticles.

Citing Articles

Structural Elucidation of Agrochemical Metabolic Transformation Products Based on Infrared Ion Spectroscopy to Improve In Silico Toxicity Assessment.

Vink M, Alarcan J, Martens J, Buma W, Braeuning A, Berden G Chem Res Toxicol. 2023; 37(1):81-97.

PMID: 38118149 PMC: 10792670. DOI: 10.1021/acs.chemrestox.3c00316.


Iron oxide nanoparticles carried by probiotics for iron absorption: a systematic review.

Ciont C, Mesaros A, Pop O, Vodnar D J Nanobiotechnology. 2023; 21(1):124.

PMID: 37038224 PMC: 10088223. DOI: 10.1186/s12951-023-01880-9.


Hyperthermia-Induced In Situ Drug Amorphization by Superparamagnetic Nanoparticles in Oral Dosage Forms.

Ansari S, Hempel N, Asad S, Svedlindh P, Bergstrom C, Lobmann K ACS Appl Mater Interfaces. 2022; 14(19):21978-21988.

PMID: 35452221 PMC: 9121342. DOI: 10.1021/acsami.2c03556.


Recent Advances in the Gastrointestinal Fate of Organic and Inorganic Nanoparticles in Foods.

Zhou H, McClements D Nanomaterials (Basel). 2022; 12(7).

PMID: 35407216 PMC: 9000219. DOI: 10.3390/nano12071099.

References
1.
Chamorro S, Gutierrez L, Vaquero M, Verdoy D, Salas G, Luengo Y . Safety assessment of chronic oral exposure to iron oxide nanoparticles. Nanotechnology. 2015; 26(20):205101. DOI: 10.1088/0957-4484/26/20/205101. View

2.
Singh S, Rahman M, Murty U, Mahboob M, Grover P . Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment. Toxicol Appl Pharmacol. 2012; 266(1):56-66. DOI: 10.1016/j.taap.2012.10.016. View

3.
Zanella D, Bossi E, Gornati R, Bastos C, Faria N, Bernardini G . Iron oxide nanoparticles can cross plasma membranes. Sci Rep. 2017; 7(1):11413. PMC: 5595914. DOI: 10.1038/s41598-017-11535-z. View

4.
Garcia-Fernandez J, Turiel D, Bettmer J, Jakubowski N, Panne U, Rivas Garcia L . and experiments to evaluate the biodistribution and cellular toxicity of ultrasmall iron oxide nanoparticles potentially used as oral iron supplements. Nanotoxicology. 2020; 14(3):388-403. DOI: 10.1080/17435390.2019.1710613. View

5.
Hilty F, Arnold M, Hilbe M, Teleki A, Knijnenburg J, Ehrensperger F . Iron from nanocompounds containing iron and zinc is highly bioavailable in rats without tissue accumulation. Nat Nanotechnol. 2010; 5(5):374-80. DOI: 10.1038/nnano.2010.79. View